The 4th annual NeoAg Summit is returning to Boston this November to provide your team with one all-inclusive forum to successfully target tumor-specific neoantigens and bring to market personalized cancer vaccines and cellular therapies.

With record numbers of neoantigen-targeted cancer immunotherapies entering the clinic, the time is now to join your community to gain a clear understanding of the leading prediction platforms and gain a comprehensive overview of the clinical landscape.